Medicinova (MNOV) Total Current Liabilities (2010 - 2026)
Medicinova (MNOV) posted quarterly Total Current Liabilities of $3.8 million for Q4 2025, up 28.33% year-over-year from $3.0 million in Q4 2024, and up 13.78% quarter-over-quarter from $3.3 million in Q3 2025.
Medicinova (MNOV) Total Current Liabilities (2010 - 2026) Analysis & Trends
Medicinova (MNOV) has reported Total Current Liabilities for 16 consecutive years, with $3.8 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Total Current Liabilities rose 28.33% year-over-year to $3.8 million; the TTM figure through Dec 2025 stood at $3.8 million (up 28.33% YoY), while the FY2025 annual figure was $3.8 million, up 28.33% from the prior year.
- Total Current Liabilities improved to $3.8 million in Q4 2025 per MNOV's latest filing, from $3.3 million in the prior quarter.
- Across five years, Total Current Liabilities topped out at $4.5 million in Q3 2022 and bottomed at $1.8 million in Q1 2021.
- Historically, Total Current Liabilities has averaged $3.0 million across 5 years, with a median of $2.8 million in 2021.
- Annual changes were most pronounced in 2021 — Total Current Liabilities surged 132.9% — and 2023, when it plunged 38.13%.
- Medicinova's Total Current Liabilities stood at $2.8 million in 2021, then climbed by 12.52% to $3.2 million in 2022, then advanced by 2.88% to $3.3 million in 2023, then fell by 9.76% to $3.0 million in 2024, then climbed by 28.33% to $3.8 million in 2025.
- Business Quant data shows MNOV's Total Current Liabilities at $3.8 million in Q4 2025, $3.3 million in Q3 2025, and $2.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.39 Bn | 132.54 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 86.47 Bn | 78.47 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 65.25 Bn | 60.07 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 61.79 Bn | 56.66 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 42.27 Bn | 37.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 31.17 Bn | 27.86 Bn | 992.69 Mn | 1.51 Bn |
| 7 | BioNTech SE | 28.61 Bn | 10.22 Bn | 668.28 Mn | 2.49 Bn |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 438.74 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | 630.93 Mn |
| 10 | Medicinova | 67.88 Mn | 67.88 Mn | 317,759.00 | 2.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.96 Mn |
| Dec 31, 2025 | 3.80 Mn |
| Sep 30, 2025 | 3.34 Mn |
| Jun 30, 2025 | 2.65 Mn |
| Mar 31, 2025 | 2.13 Mn |
| Dec 31, 2024 | 2.96 Mn |
| Sep 30, 2024 | 2.60 Mn |
| Jun 30, 2024 | 2.49 Mn |
| Mar 31, 2024 | 2.51 Mn |
| Dec 31, 2023 | 3.28 Mn |
| Sep 30, 2023 | 2.80 Mn |
| Jun 30, 2023 | 2.82 Mn |
| Mar 31, 2023 | 2.72 Mn |
| Dec 31, 2022 | 3.19 Mn |
| Sep 30, 2022 | 4.53 Mn |
| Jun 30, 2022 | 3.84 Mn |
| Mar 31, 2022 | 2.98 Mn |
| Dec 31, 2021 | 2.83 Mn |
| Sep 30, 2021 | 4.20 Mn |
| Jun 30, 2021 | 2.47 Mn |